PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT

Journal article

Peer reviewed

C. Y. Cheah, N. N. Shah, W. Jurczak, P. Luigi Zinzani, T. A. Eyre, C. S. Ujjani, K. Izutsu, S. Ma, I. Flinn, A. J. Alencar, …

Hematological oncology, Vol.41(S2), pp.153-156

2023-06

Metrics

1 Record Views

Title: PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT
Creators: C. Y. Cheah - University of Western Australia
N. N. Shah - Medical College of Wisconsin
W. Jurczak - The Maria Sklodowska-Curie National Research Institute of Oncology
P. Luigi Zinzani - Istituto di Ematologia di Bologna
T. A. Eyre - University of Oxford
C. S. Ujjani - University of Washington
K. Izutsu - Tokyo National Hospital
S. Ma - Northwestern University
I. Flinn - Tennessee Oncology
A. J. Alencar - Sylvester Comprehensive Cancer Center
D. Lewis - Derriford Hospital
K. Patel - Swedish Medical Center
K. Maddocks - The Ohio State University
Y. Wang - Mayo Clinic
T. Munir - St James's University Hospital
A. D. Zelenetz - Memorial Sloan Kettering Cancer Center
M. Balbas - [email protected], Indianapolis, Indiana, USA
D. E. Tsai - [email protected], Indianapolis, Indiana, USA
C. Wang - Eli Lilly
M. L. Wang - The University of Texas MD Anderson Cancer Center
Publication Details: Hematological oncology, Vol.41(S2), pp.153-156
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031821240002976